ATXA Therapeutics will be attending the 23rd Bio€quity Europe Conference, due to be held from May 14 – 16, 2023, in Dublin’s Convention Centre. For more than 20 years, Bio€quity Europe has been a premier forum where CEOs and investors can gather to network, partner and debate critical issues facing the biotech industry today.
ATXA Founder and CEO Prof. Therese Kinsella will also participate in a panel discussion on Monday, May 15, from 4.00 pm – 5.15 pm. This plenary session – titled “A Spotlight on Irish Biotech” – will feature ATXA Therapeutics and several other Irish biotech successes and will discuss the global reputation that Ireland's pharma sector has for operational and manufacturing excellence, and how Irish research institutes are renowned for producing world-class science.
Chaired by Dr Mary Martin (Avectas), the panelists will also debate the need for more early-stage funding and greater investment in human capital to drive entrepreneurship in drug discovery and translational science to accelerate growth of Irish biotech. Additional panelists include Mark Barrett (APC), Loretto Callaghan (Vzarii Therapeutics), Daniel Crowley (Remedy Biologics), Luke O'Neill (TCD, Inflazome), and Kieran Rooney (Amryt Pharma).